Executives will need to ... craft a whole-person care plan.
National Reports-Since Sherry Huff, 54, from San Antonio, Texas, had bariatric surgery in December 2003, she has lost more than 100 pounds. Aside from the obvious benefits for her-being able to travel easily and walk without pain-Huff also saw an immediate reduction in her healthcare costs.
Prior to her surgery, Huff took 14 pills and three insulin shots per day for high blood pressure, high cholesterol, diabetes and other ailments. Her out-of-pocket medication costs were $500 per month and her insurer paid another $1,000 per month. Six months post-op, Huff takes no medication on a regular basis and the only remaining health condition is asthma. She is convinced that the weight loss is responsible for her not having an asthma attack for six months.
While obesity surgery is expensive-total cost is in the $20,000 to $25,000 range-it begins an almost immediate payoff in terms of direct medical costs, according to John Pilcher, MD, Surgical Consultants of San Antonio. "Patients commonly reduce their medication requirements from 10 to 15 prescription drugs to three or less, and this reduction occurs within six months of surgery," Dr. Pilcher says. "The rate of hospitalization for heart failure, asthma, reflux disease, joint replacement and similar problems is dramatically reduced. The need for ongoing diabetic care almost goes away. In terms of direct medical costs, current estimates place the break-even point at three to five years from surgery."
The recent Medicare legislation that enables Medicare to consider paying for obesity treatments probably will make it necessary, one way or another, for plans to cover effective therapies for obesity.
Eric Parmenter, Midwest region practice leader, compensation and benefits consulting at Grant Thornton LLP, believes there is a danger in opening up coverage for weight-loss treatments such as stomach stapling. "If it is not incorporated into a holistic approach, then the individual will put the weight back on, and it will be a waste of money. Executives need to draw upon other areas of covered expenses, such as treatment for other illnesses and prevention to craft a whole-person care plan that incorporates the new coverage for weight loss," Parmenter says.
Thomas G. Lundquist, MD, executive vice president and chief medical officer at I-trax, a health and productivity company, shares a similar viewpoint. "A public and population health management strategy is needed," Dr. Lundquist says. "Only that would begin to address the growing obesity problem in America, thereby leading to population-based clinical improvement and desired outcomes."
As an alternative to surgery, executives can prepare their plans to investigate the new generation of corporate wellness programs, says Aaron Day, CEO at Boston-based Realize, a corporate weight-loss management company that provides a solution for employees to better manage their health and to be monetarily rewarded for their progress. "The best of these are designed to motivate employees and their spouses ... by measuring, tracking and rewarding employees for achieving and maintaining improved health goals," Day says.
Cognitive behavioral therapy, such as that provided by Selfhelpworks, targets root emotional causes of obesity, says Alan Edwards, Selfhelpworks president. "[Addressing] the root causes, in turn, erases the need for more expensive, symptomology-based treatment options such as surgery," he says. Selfhelpworks is working with WellPoint and government agencies such as the Department of Human Services at the State of Texas to employ such therapies.
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen
Upended: Can PBM Transparency Succeed?
March 6th 2024Simmering tensions in the pharmacy benefit management (PBM) industry have turned into fault lines. The PBMs challenging the "big three" have formed a trade association. Purchaser coalitions want change. The head of the industry's trade group says inherent marketplace friction has spilled over into political friction.
Read More
Briana Contreras, editor of Managed Healthcare Executive, spoke with Nancy Lurker, CEO and president of EyePoint Pharmaceuticals. Nancy shared a bit about EyePoint and how the organization’s innovative therapies are addressing patient needs through eye care, and most importantly, she addressed C-Suite positions like the CEO role. Nancy shared advice for those seeking to reach the CEO level, especially toward women in healthcare and other roles, and what it takes to run a biopharma company.
Listen
The deliberate disconnection of Change Healthcare to ring fence a cyberattack entered its seventh day today. Prescribers are finding ways to get pharmacy claims processed, and UnitedHealth Group says disruption to the dispensing of prescriptions has been minimal. But independent pharmacies want more information and protection from financial consequences from pharmacy benefit managers.
Read More
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen
Upended: Can PBM Transparency Succeed?
March 6th 2024Simmering tensions in the pharmacy benefit management (PBM) industry have turned into fault lines. The PBMs challenging the "big three" have formed a trade association. Purchaser coalitions want change. The head of the industry's trade group says inherent marketplace friction has spilled over into political friction.
Read More
Briana Contreras, editor of Managed Healthcare Executive, spoke with Nancy Lurker, CEO and president of EyePoint Pharmaceuticals. Nancy shared a bit about EyePoint and how the organization’s innovative therapies are addressing patient needs through eye care, and most importantly, she addressed C-Suite positions like the CEO role. Nancy shared advice for those seeking to reach the CEO level, especially toward women in healthcare and other roles, and what it takes to run a biopharma company.
Listen
The deliberate disconnection of Change Healthcare to ring fence a cyberattack entered its seventh day today. Prescribers are finding ways to get pharmacy claims processed, and UnitedHealth Group says disruption to the dispensing of prescriptions has been minimal. But independent pharmacies want more information and protection from financial consequences from pharmacy benefit managers.
Read More
2 Commerce Drive
Cranbury, NJ 08512